Literature DB >> 24247220

Deregulation of microRNA expression in thyroid neoplasias.

Pierlorenzo Pallante1, Sabrina Battista1, Giovanna Maria Pierantoni1, Alfredo Fusco1.   

Abstract

MicroRNAs (miRNAs) have emerged as a class of powerful gene expression regulators. Acting at the post-transcriptional level, miRNAs modulate the expression of at least one-third of the mRNAs that are encoded by the human genome. The expression of a single gene can be regulated by several miRNAs, and every miRNA has more than one target gene. Thus, the miRNA regulatory circuit, which affects essential cellular functions, is of enormous complexity. Moreover, a fundamental role for miRNAs has been determined in the onset and progression of human cancers. Here, we summarize the main alterations in miRNA expression that have been identified in thyroid neoplasias and examine the mechanisms through which miRNA deregulation might promote thyroid cell transformation. We also discuss how the emerging knowledge on miRNA deregulation could be harnessed for the diagnosis and treatment of thyroid neoplasias.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24247220     DOI: 10.1038/nrendo.2013.223

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  214 in total

1.  MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer.

Authors:  Yi Chen; Mohd Saif Zaman; Guoren Deng; Shahana Majid; Shranjot Saini; Jan Liu; Yuichiro Tanaka; Rajvir Dahiya
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-11

Review 2.  New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites.

Authors:  Isidore Rigoutsos
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

3.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

4.  MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.

Authors:  Deepak Abraham; Nicole Jackson; Justin S Gundara; JingTing Zhao; Anthony J Gill; Leigh Delbridge; Bruce G Robinson; Stan B Sidhu
Journal:  Clin Cancer Res       Date:  2011-05-27       Impact factor: 12.531

5.  Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice.

Authors:  C Ledent; J Dumont; G Vassart; M Parmentier
Journal:  Endocrinology       Date:  1991-09       Impact factor: 4.736

6.  Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?

Authors:  Sandra Lassalle; Véronique Hofman; Marius Ilie; Christelle Bonnetaud; Marie-Pierre Puisségur; Patrick Brest; Céline Loubatier; Nicolas Guevara; Olivier Bordone; Bruno Cardinaud; Kévin Lebrigand; Géraldine Rios; Joseph Santini; Brigitte Franc; Bernard Mari; Abir Al Ghuzlan; Philippe Vielh; Pascal Barbry; Paul Hofman
Journal:  Endocr Relat Cancer       Date:  2011-09-13       Impact factor: 5.678

7.  MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene.

Authors:  G Ke; L Liang; J M Yang; X Huang; D Han; S Huang; Y Zhao; R Zha; X He; X Wu
Journal:  Oncogene       Date:  2012-07-30       Impact factor: 9.867

8.  The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.

Authors:  Tong Sun; Qianben Wang; Steven Balk; Myles Brown; Gwo-Shu Mary Lee; Philip Kantoff
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

9.  Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.

Authors:  Chen-Kai Chou; Kuender D Yang; Fong-Fu Chou; Chao-Cheng Huang; Yueh-Wen Lan; Ya-Fang Lee; Hong-Yo Kang; Rue-Tsuan Liu
Journal:  J Clin Endocrinol Metab       Date:  2012-12-21       Impact factor: 5.958

10.  Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma.

Authors:  Johannes H Schulte; Tobias Marschall; Marcel Martin; Philipp Rosenstiel; Pieter Mestdagh; Stefanie Schlierf; Theresa Thor; Jo Vandesompele; Angelika Eggert; Stefan Schreiber; Sven Rahmann; Alexander Schramm
Journal:  Nucleic Acids Res       Date:  2010-05-13       Impact factor: 16.971

View more
  57 in total

Review 1.  Polycomb protein family member CBX7 plays a critical role in cancer progression.

Authors:  Pierlorenzo Pallante; Floriana Forzati; Antonella Federico; Claudio Arra; Alfredo Fusco
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

2.  Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression.

Authors:  F Rosignolo; V Maggisano; M Sponziello; M Celano; C R T Di Gioia; M D'Agostino; L Giacomelli; A Verrienti; M Dima; V Pecce; C Durante
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

3.  MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors.

Authors:  Veronika Mancikova; Esmeralda Castelblanco; Elena Pineiro-Yanez; Javier Perales-Paton; Aguirre A de Cubas; Lucia Inglada-Perez; Xavier Matias-Guiu; Ismael Capel; Maria Bella; Enrique Lerma; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Francisco Maravall; Didac Mauricio; Fatima Al-Shahrour; Mercedes Robledo
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

Review 4.  Current methodologies for molecular screening of thyroid nodules.

Authors:  Elisabetta Macerola; Fulvio Basolo
Journal:  Gland Surg       Date:  2018-08

5.  miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas.

Authors:  Nicla Borrelli; Maria Denaro; Clara Ugolini; Anello Marcello Poma; Mario Miccoli; Paolo Vitti; Paolo Miccoli; Fulvio Basolo
Journal:  Mod Pathol       Date:  2016-09-02       Impact factor: 7.842

6.  CBX7 Expression in Oncocytic Thyroid Neoplastic Lesions (Hürthle Cell Adenomas and Carcinomas).

Authors:  Mario Monaco; Gennaro Chiappetta; Concetta Aiello; Antonella Federico; Romina Sepe; Daniela Russo; Alfredo Fusco; Pierlorenzo Pallante
Journal:  Eur Thyroid J       Date:  2014-10-15

Review 7.  Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes.

Authors:  Maryam Zarkesh; Azita Zadeh-Vakili; Fereidoun Azizi; Forough Foroughi; Maziar Mohammad Akhavan; Mehdi Hedayati
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

8.  Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.

Authors:  Emmanuel Labourier; Alexander Shifrin; Anne E Busseniers; Mark A Lupo; Monique L Manganelli; Bernard Andruss; Dennis Wylie; Sylvie Beaudenon-Huibregtse
Journal:  J Clin Endocrinol Metab       Date:  2015-05-12       Impact factor: 5.958

9.  MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19.

Authors:  Yanping Gong; Wenshuang Wu; Xiuhe Zou; Feng Liu; Tao Wei; Jingqiang Zhu
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

10.  Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors.

Authors:  Maria Laura Ester Bianchi; Emanuele Leoncini; Marcella Masciullo; Anna Modoni; Shahinaz M Gadalla; Roberto Massa; Emanuele Rastelli; Chiara Terracciano; Giovanni Antonini; Elisabetta Bucci; Antonio Petrucci; Sandro Costanzi; Massimo Santoro; Stefania Boccia; Gabriella Silvestri
Journal:  J Neurol       Date:  2016-01-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.